Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

47.57 +0.14 (+0.30%)
Official Closing Price Updated: 7:00 PM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,472,474
Open 47.63
Bid (Size) 47.58 (500)
Ask (Size) 47.66 (400)
Prev. Close 47.43
Today's Range 47.30 - 48.11
52wk Range 43.08 - 112.52
Shares Outstanding N/A
Dividend Yield 4.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year ↗
A key catalyst may be right around the corner. 
Via The Motley Fool
News headline image
Medicare Just Cut the Price of Wegovy: Should You Sell Novo Nordisk Stock? ↗
There is more to this news than meets the eye. 
Via The Motley Fool
Topics Economy Government

Performance

YTD
-45.6%
-45.6%
1 Month
-3.1%
-3.1%
3 Month
-16.2%
-16.2%
6 Month
-34.0%
-34.0%
1 Year
-56.4%
-56.4%

More News

Read More
News headline image
Novo Nordisk Defends Semaglutide Alzheimer’s Trials After Studies Miss Goals ↗
Via Stocktwits
News headline image
The Shifting Tides: How Retail and Institutional Forces Reshape Market Dynamics
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study ↗
Via Stocktwits
Novo Nordisk Stock Tumbles: HSBC Downgrades After ‘Lottery Ticket’ Alzheimer’s Bet Fails, But Retail Traders Call Selloff ‘Ridiculous’ ↗
Via Stocktwits
News headline image
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
News headline image
Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Eli Lilly Cuts Prices For Weight Loss Drug Zepbound To $299 A Month As It Takes On Novo Nordisk’s Wegovy ↗
Via Stocktwits
Topics Economy Government
News headline image
Novo Nordisk's Latest Clinical Result Is Sending the Stock Plunging. Here's What Investors Need to Know. ↗
Via The Motley Fool
News headline image
This 7% Yielder Could Be a Top AI Play ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Why Novo Nordisk Stock Just Hit a 4-Year Low ↗
Via The Motley Fool
News headline image
Novo Nordisk A/S (NYSE:NVO) Offers a Strong Dividend and Sound Fundamentals ↗
Via Chartmill
News headline image
Novo Nordisk Stock Investors Get Huge News on Drug Trial Results ↗
Via The Motley Fool
News headline image
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 ↗
Via The Motley Fool
News headline image
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
Via Stocktwits
Topics ETFs
News headline image
JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗
Via Stocktwits
Topics Economy Government
News headline image
Why Novo Nordisk Stock Is Moving Higher Today ↗
Via The Motley Fool
Topics Stocks
News headline image
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗
Via Investor's Business Daily
Topics Economy Government
News headline image
Did Pfizer Just Say "Checkmate" to Novo Nordisk? ↗
Via The Motley Fool
News headline image
Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗
Via Stocktwits
News headline image
Here's Why Novo Nordisk Stock Popped Today ↗
Via The Motley Fool
News headline image
Novo Nordisk (NYSE:NVO) Presents a Compelling Case for Value Investors ↗
Via Chartmill
News headline image
Why Novo Nordisk Stock Sank 5.6% Today ↗
Via The Motley Fool
Topics Stocks
News headline image
Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗
Via MarketBeat

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 47.57
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/03/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.